CBP 400 (Spectracef 400 mg)
Generic Name: cefditoren
Pill imprint CBP 400 has been identified as Spectracef 400 mg.
Spectracef is used in the treatment of skin and structure infection; skin or soft tissue infection; pneumonia; tonsillitis/pharyngitis; bronchitis and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Spectracef 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- cefditoren
- Imprint:
- CBP 400
- Strength:
- 400 mg
- Color:
- White
- Size:
- 5.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Cornerstone BioPharma Inc
- National Drug Code (NDC):
- 10122-0802
- Inactive Ingredients:
- croscarmellose sodium
mannitol
magnesium stearate
sodium caseinate
sodium tripolyphosphate
hydroxypropyl cellulose
carnauba wax
polyethylene glycol
titanium dioxide
More about Spectracef (cefditoren)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
